R&D Systems™ Recombinant Cynomolgus B7-H6 Fc Chimera Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems™ 8984B701M
DescriptionMeasured by its ability to induce IFN-gamma secretion by NK-92 human natural killer lymphoma cells. Brandt, C.S. et al. (2009) J. Exp. Med. 206:1495. The ED50 for this effect is 0.5-2.5 μg/mL.
|Lyophilized from a 0.2 µm filtered solution in PBS.|
|M.W. (Observed): 70-81 kDa, reducing conditions; M.W. (theoretical): 53 kDa|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.|
|B7 homolog 6, B7H6, B7-H6, DKFZp686I21167, DKFZp686O24166, NCR3LG1|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.|
|Human embryonic kidney cell, HEK293-derived cynomolgus monkey B7-H6 protein Cynomolgus B7-H6 (Asp25-Ser262) (N-terminus) Accession # XP_005578557 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)|
|<0.10 EU / 1 µg of the protein by the LAL method.|
|Reconstitute at 100 µg/mL in PBS.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok